Intervention

Laboratory Biomarker Analysis

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 424 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials424
Recruiting12
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung CancerNCT05558904 · 2023-01-19
RECRUITING
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296 · 2021-02-21
RECRUITING
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyNCT04472338 · 2020-05-21
RECRUITING
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityNCT03418961 · 2017-11-01
RECRUITING
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerNCT03199651 · 2017-07-17
RECRUITING
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyNCT02945579 · 2017-01-20
RECRUITING
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusNCT02479698 · 2015-07-23
RECRUITING
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast CancerNCT02610413 · 2014-03-25
RECRUITING
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast CancerNCT02610426 · 2014-03-25
RECRUITING
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast CancerNCT02610439 · 2014-03-25
RECRUITING
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentNCT01790152 · 2014-03-05
RECRUITING
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerNCT01050504 · 2009-08-01
RECRUITING
Incidence of HIV Infection in Screening Indian Men Who Have Sex With MenNCT04142385 · 2027-04-30
WITHDRAWN
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive MenNCT04142398 · 2027-04-30
WITHDRAWN
Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast CancerNCT05244434 · 2022-07-03
WITHDRAWN
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyNCT04692103 · 2021-07-10
ACTIVE_NOT_RECRUITING
Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus InfectionNCT03601806 · 2021-04-26
COMPLETED
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLCNCT04754815 · 2021-04-01
WITHDRAWN
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA TrialNCT04624256 · 2020-11-10
ACTIVE_NOT_RECRUITING
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesNCT02962661 · 2020-07-18
SUSPENDED
Fluid Biopsy for the Diagnosis of Lung CancerNCT04162678 · 2020-01-13
TERMINATED
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPVNCT03284866 · 2019-07-31
COMPLETED
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerNCT03091842 · 2019-07-29
WITHDRAWN
High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate CancerNCT03514927 · 2019-07-01
WITHDRAWN
M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate CancerNCT03517969 · 2019-05-29
ACTIVE_NOT_RECRUITING
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After SurgeryNCT03515577 · 2019-04-12
COMPLETED
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid CancersNCT03868423 · 2019-03-20
WITHDRAWN
Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer SurvivorsNCT03120390 · 2019-03-08
WITHDRAWN
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsNCT03407716 · 2019-03-01
COMPLETED
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisNCT03317392 · 2019-02-04
ACTIVE_NOT_RECRUITING
Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the BoneNCT03529565 · 2019-01-31
TERMINATED
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryNCT03152786 · 2019-01-15
TERMINATED
Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS StudyNCT04254133 · 2018-11-30
ENROLLING_BY_INVITATION
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate CancerNCT03344211 · 2018-11-21
ACTIVE_NOT_RECRUITING
Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and VincristineNCT03596918 · 2018-10-10
COMPLETED
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural MesotheliomaNCT03126630 · 2018-10-04
ACTIVE_NOT_RECRUITING
ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung CancerNCT03402880 · 2018-10-01
WITHDRAWN
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by SurgeryNCT03218826 · 2018-09-24
COMPLETED
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal LesionsNCT03603808 · 2018-09-21
COMPLETED
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerNCT03238703 · 2018-09-01
WITHDRAWN
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerNCT03516812 · 2018-08-29
COMPLETED
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate CancerNCT03361735 · 2018-08-29
ACTIVE_NOT_RECRUITING
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair DeficiencyNCT03442556 · 2018-08-24
TERMINATED
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)NCT03526250 · 2018-08-13
COMPLETED
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung CancerNCT03455556 · 2018-08-10
TERMINATED
Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast CancerNCT03377101 · 2018-08-07
WITHDRAWN
Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast CancerNCT03477396 · 2018-06-14
COMPLETED
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate CancerNCT03406858 · 2018-06-07
COMPLETED
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)NCT03210714 · 2018-06-05
ACTIVE_NOT_RECRUITING
Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT02966587 · 2018-05-15
WITHDRAWN
Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryNCT03326258 · 2018-04-20
WITHDRAWN
MRI Characterization of Mammographically Detected DCISNCT03495011 · 2018-04-20
ACTIVE_NOT_RECRUITING
Treatment of Refractory Nausea and Vomiting in Patients With Breast CancerNCT03367572 · 2018-04-19
COMPLETED
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer SurvivorsNCT03523195 · 2018-04-18
COMPLETED
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)NCT03213652 · 2018-04-17
ACTIVE_NOT_RECRUITING
Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung CancerNCT02937402 · 2018-04-05
TERMINATED
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerNCT03432741 · 2018-03-27
TERMINATED
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerNCT03087708 · 2018-03-23
TERMINATED
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate CancerNCT03456843 · 2018-03-20
ACTIVE_NOT_RECRUITING
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasNCT03220022 · 2018-03-16
ACTIVE_NOT_RECRUITING

Common conditions

Trial status mix

COMPLETED210
ACTIVE_NOT_RECRUITING84
TERMINATED79
WITHDRAWN27
RECRUITING12
SUSPENDED5
UNKNOWN5
ENROLLING_BY_INVITATION1
NO_LONGER_AVAILABLE1

Phase mix

PHASE2205
PHASE1121
NA58
PHASE339
EARLY_PHASE16
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.